Surgeon contracts CANCER from patient
A surgeon accidentally contracted cancer from a patient in a first of its kind occurrence. The patient, a 32-year-old man from Germany, had a unique form of cancer and was undergoing surgery to remove a tumour from his abdomen.
During the operation, the surgeon accidentally cut his hand. Although he cleaned and bandaged the wound right away, five months later, a small lump appeared at the injury site. When examined, it was found to be a malignant tumour, genetically identical to the cancer from the patient.
I lost my hands, girlfriend, dad’s landed properties survived depression; but I’m alive’
The medical team concluded that the surgeon likely caught the cancer when tumour cells entered the cut. The case was unusual because normally, the body fights off foreign tissue, which would have been expected in this situation. However, the tumour’s growth indicated the surgeon’s immune system did not effectively respond to the cancer cells.
Originally reported in 1996, this case gained new attention after being published in The New England Journal of Medicine. The report detailed how the surgeon injured his left hand while placing a drain during surgery. Despite the patient’s initial success in surgery, he later passed away due to complications.
Months later, a hard swelling appeared on the surgeon’s finger. Although tests showed no initial abnormalities, the growth was ultimately found to be a malignant fibrous histiocytoma.
Both tumours were analysed and declared identical, suggesting that cancer cells from the patient had entered the surgeon’s body through the cut. The report emphasized that normally, the immune system would reject transplanted tissue.
In this case, while there was inflammation around the tumour, it still increased in size, indicating a failure of the immune response. Researchers proposed that the tumour might have escaped destruction by changing its cell molecules and evading the surgeon’s immune system.
Two years after the surgeon had his tumour removed, there were no signs of cancer returning. The study also highlighted cases where heart transplant patients adopt traits from their donors.
Doctors found the case intriguing because the transplanted tissue is different from the host’s tissue, making it a target for the immune system, which tries to reject it. This is why people who receive organ transplants need to take immunosuppressive medications to prevent their bodies from rejecting the new organ.
In this specific situation, although the surgeon experienced inflammation around his original incision, his immune system did not stop the tumor from growing. Instances like the surgeon’s are very rare, and there are no reliable statistics on cancer that is transferred through organ transplants.
A review published in 2013 in Cold Spring Harbor Perspectives in Medicine noted the difficulty in estimating the risk of cancer being transmitted from donor to recipient, highlighting the lack of comprehensive data on the topic. The authors mentioned that the chances of cancer transmission are so low that only sporadic case reports provide insights.
A previous review from 1993 that examined data from the 1970s also indicated only a few isolated reports of cancer being transmitted through organ donations. The 2013 review stated that the infrequency and varying stages of cancers make it impossible to calculate a definitive risk.
However, the authors pointed out that the available data likely underestimates the actual occurrence of such cases. Based on limited information, the 2013 report identified several types of cancers that have been known to transmit from donor to recipient, including breast cancer, colon cancer, liver cancer, lung cancer, melanoma, ovarian cancer, prostate cancer, and renal cancer.
